by nbalawdesign | Mar 1, 2021 | Uncategorized
Richard J. Arsenault, Neblett, Beard & Arsenault’s senior and founding partner, will be presenting information on Actos at the American Association for Justice’s Actos Teleseminar on September 8 at 2:00pm-3:30pm ET. According to an FDA warning, prolonged use of...
by nbalawdesign | Mar 1, 2021 | Uncategorized
After an 11-week trial, a Louisiana jury rendered a historic verdict: $9 billion in punitive damages against Eli Lilly and Takeda Pharmaceuticals over claims that taking Actos increases bladder cancer risks. Richard J. Arsenault, along with co-trial counsel W. Mark...
by nbalawdesign | Mar 1, 2021 | Uncategorized
There is an ongoing battle that has been quietly taking place for years. Unfortunately, most Americans are clueless of its existence or consequences. Despite it at best being background noise to most, the “preemption” debate raises fundamental questions about how our...
by nbalawdesign | Mar 1, 2021 | Uncategorized
Attorney Richard J. Arsenault, senior partner of Alexandria, LA-based Neblett, Beard & Arsenault, has been selected to serve as co-lead counsel for plaintiffs in emerging class action litigation against the makers of Kaba Simplex Keyless locks. The following is an...
by nbalawdesign | Mar 1, 2021 | Uncategorized
Attorney Richard J. Arsenault, founding and senior partner of Neblett, Beard & Arsenault, served as co-chair at HarrisMartin Publishing’s Zimmer NexGen Knee and DePuy Hip Implant Litigation Conference. In addition to chairing the event, Arsenault also gave a...
